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Introduction
Cancer dormancy, the phenomena that the tumor's volume or the number of tumor cells stays at a very low level for a certain period of time before the tumor begins to grow rapidly, has been an outstanding issue in cancer research for many years [1, 2] . Currently, the mechanisms responsible for the "switch" from a dormant state to a rapid growth state for different tumors are not well understood, although it is well known that such a "switch" in secondary metastatic tumors can be triggered by the removal of the primary tumor. This could eventually lead to failure of tumor treatment and fatal outcomes for the patient. Therefore, a comprehensive understanding of the "switch" from a dormant to a proliferative state is crucial to our fundamental understanding of cancer progression and recurrence and might lead to the development of novel treatments for cancer.
Dormancy has been observed in many types of cancer. This includes tumor dormancy before any metastases take place and the latency of cancer recurrence after therapy. In some cases of pancreatic cancer, the tumor can remain in a benign dormant state for about 20 years [3] . During this time, it is undetectable by conventional clinical methods, and it is only afterwards that the tumor becomes highly malignant and grows aggressively with highly fatal outcomes after about a year. In the cases of breast and prostate cancer, it is reported that 20%-45% of patients will relapse years or decades later after the resection of the primary tumor [4] [5] [6] . In addition, recurrence has been observed in brain tumors, which indicates the existence of a large number of micrometastases that are dormant in the presence of the primary tumor [7, 8] .
Extensive studies over years have revealed three major cancer dormancy mechanisms: cellular dormancy, angiogenic dormancy and immunosurveillance [1, 2] . On the cellular level, a tumor cell could be arrested at a certain stage of the cell cycle and unable to complete the cell division process successfully, resulting in a dormant solitary cell [9] [10] [11] ].
On the cell population level, when the population does not gain enough ability to recruit blood vessels and promote neovascularization, the tumor cannot obtain sufficient nutrients necessary for its proliferation and as a result, angiogenic dormancy occurs [12, 13] . On other hand, immunosurveillance operates when the immune system suppresses the proliferation of tumor cell population and leads to the dormancy of the tumor [14] [15] [16] [17] [18] . Figure 1 A comprehensive understanding of cancer dormancy and the "switch" from a dormant to a proliferative state still needs to be strengthened. This is mainly due to the fact that efficient and accurate experimental or clinical approaches to track the states of individual cells in a dormant tumor in vivo throughout the entire dormancy period are still under development [19] [20] [21] .
Given the current need for further understanding of dormancy, computational modeling provides a powerful means to probe various scenarios for the underlying mechanisms. Specifically, modeling enables one to probe a variety of different dormancy scenarios by examining different combinations of mechanisms in order to see which ones provide possible explanations for experimental and clinical observations. Over the past few decades, computational modeling has played an important role in the study of the progression of solid tumors [22] ; a variety of models based on different mathematical schemes have been developed, including continuum models [23] [24] [25] [26] , discrete cell models [27, 28] and hybrid models [29, 30] . Various models have been used to investigate cancer dormancy caused by cancer-immune interactions and other mechanisms, including ordinary differential equation-based models [31, 32] , stochastic differential equation-based models [33] , models based on kinetic theory for active particles [34] [35] [36] , and cellular automaton models [37] . However, the aforementioned studies neither explicitly demonstrated how the dynamic process of active proliferation after a certain period of dormancy emerges from various microscopic mechanisms nor showed the associated growth dynamics of the "switch" phenomenon.
Therefore, predictive computational models that incorporate cellular-level microscopic mechanisms are needed to address these important issues.
In this paper, we generalize a two-dimensional (2D) cellular automaton (CA) model that we have devised to study proliferative growth of avascular solid tumors [38] [39] [40] [41] [42] 
Materials and Methods
We divide the two-dimensional square simulation box into different polygonal units (i.e., automaton • Quiescent cells more than a certain distance δ n from the tumor's edge are turned necrotic.
The tumor's edge, which is assumed to be the source of nutrients, consists of all ECMassociated cells that border the tumor. The critical distance δ n for quiescent cells to turn necrotic is computed as follows:
where a is the necrotic thickness controlled by nutritional needs, d is the Euclidean spatial dimension and L t is the distance between the geometric centroid x c of the tumor (i.e.,
where N is the total number of cells in the tumor) and the tumor edge cell that is closest to the quiescent cell under consideration.
• Proliferative cells more than a certain distance δ p from the tumor's edge are turned quiescent.
The critical distance δ p is given by
where b is the proliferative thickness controlled by nutritional needs, d is the spatial dimension and L t is the distance between the geometric tumor centroid x c and the tumor edge cell that is closest to the proliferative cell under consideration.
• The probability of division for a proliferative cell used in our model is
. (3) where p 0 = 0.192 is the base probability of di-
ECM is a parameter taking into account the effect of pressure,
ECM is the ratio of current average ECM density over the initial density, and ℓ and w are, respectively, the length and width of local protrusion tips.
Interactions between the tumor and the microenvironmental suppression factors
Here, we specify the additional interaction rules between the tumor and the microenvironmental suppression factors beyond the aforementioned ones for noninvasive proliferative growth, which were not included in our previous CA models. We assume that there are two possible states of proliferative cells, dormant or actively dividing, depending on their interactions with the microenvironmental suppression factors.
• Initially, we assume that all proliferative cells are kept in dormant states by the microenvironmental suppression factors, which means that they are not able to divide.
• At each day, beyond the aforementioned CA rules for proliferative noninvasive growth, each dormant proliferative cell has a certain probability γ to change in their phenotypes due to intracellular factors or external stimulus. The cell with phenotype change gains different degrees of resistance to the suppression factors in the microenvironment, depending on the specific phenotype change the cell undergoes.
For example, mutated leukaemic cells in acute myeloid leukaemia acquire resistance to cytotoxic T lymphocytes-mediated cell lysis, whose degree is related to the level of the cell's expression of B7-H1 or B7.1 [45] . For simplicity, we divide the phenotypic changes into two different types: weak changes and strong changes with respect to their resistance to the suppression factors in the microenvironment (i.e. their ability to actively proliferate). Henceforth, we will refer to these phenotypic changes as "transformations" and the cells that undergo these changes as "transformed" cells for simplicity. Strong-type "transformed" cells gain a larger competition advantage and thus have a greater ability to divide actively. The quantities x W and x S are the fractions of weak-type "transformations" and strong-type "transformations". Henceforth, we set x W 0.99 and x S 0.01.
• At each subsequent day, the microenvironmental suppression factors will counteract the weak-type "transformed" and strong-type "transformed" cells with probabilities α W and α S . The suppression factors in the microenvironment will either kill the "transformed" cells or turn them back into dormant cells [14, 15] .
• When the number of tumor cells reaches a certain threshold N T , strong reactions of the microenvironmental factors are triggered and those factors start to kill the "transformed" cells. The parameter N T is introduced to ensure that the tumor is not completely removed by the microenvironmental suppression factors.
Note that the particular choice of N T barely has any effect on the simulation results within a relatively wide range of N T values. In this work N T is set to be 50, a sufficiently small value that leads to biophysically realistic outcomes. As the tumor grows, the microenvironmental factors are weakened by the tumor, resulting in weaker suppression of the tumor cells [46, 47] . Therefore, when the microenvironmental factors counteract the "transformed" cells, the fraction of the cells that are killed can be coupled with the growth rate of the tumor by 
where a 0 = 0.58 mm The aforementioned additional parameters associated with the new rules that we employ for dormancy (beyond the ones for noninvasive proliferative growth) are summarized in Table 1 . These parameters are sufficient to formulate a model in which the transition from "dormant" to proliferative state emerges spontaneously. Note that unlike other parameters listed in Table 1 
Noninvasive proliferative tumor growth under suppression
Here, we specify how the additional interaction rules are coupled together with the original CA rules for noninvasive proliferative tumor growth, resulting in noninvasive proliferative tumor growth under suppression.
• As mentioned above, proliferative cells in the dormant state do not divide. Only proliferative cells in actively dividing states actually proliferate.
• At each day, each dormant proliferate cell is checked to see if it enters the active state according to the interaction rules. Once it begins to actively divide, it proliferates according to the CA rules for proliferative tumor growth.
• At each day, each active proliferative cell is checked to see if it is killed or turned back into dormant cell according to the interaction rules.
• Quiescent cells and necrotic cells act accord- 
Results
In this section, we apply our CA model and show that it produces a dormancy period of the tumor that can lead to a subsequent emergent "switch" behavior to a proliferative state. A homogeneous distribution of ECM density is used for simplicity [41] . A circular growth permitting region containing 
Statistics of tumor growth
Here we consider the growth of a proliferative tumor 
Suppression rate vs transformation rate
Here we investigate growth dynamics of the tumor under different suppression rates α and phenotypic transformation rates γ. The suppression rate α is defined as the following weighted average: cesses [51] . Those mechanotransduction effects will be incorporated into our CA dormancy model in future work, which could result in different scenarios from those reported here [51] .
Strength of the suppression factors
Here we investigate how tumor growth dynamics changes with the strength of the microenvironmental suppression factors. As shown in Figure 6 , increasing the fraction of actively dividing tumor cells that are killed [i.e., increasing k 0 in the equation (4)] when the microenvironmental suppression factors (which we recall could either kill the "trans- Specifically, our work shows that even if the immune system maintains its strength throughout the tumor growth process, there is still a high possibility that the immune system could eventually fail, which is to be contrasted with the simple explanations that it becomes weaker as the tumor develops [15] [16] [17] [18] .
Also, for a tumor of a specific type, we can extract the parameter values in our model by fitting our simulation results to the statistics of a real in-vitro or in-vivo tumor of this type. Then we can utilize our model to explore optimal treatment strategies for the tumors of this specific type. In addition, once we determine the effects of a specific microenvironmental factor (e.g., specific integrins [59] ) on the parameter values in our model, we could then study the effects of this microenvironmental factor on the tumor growth dynamics.
Our current CA dormancy model is still preliminary, and to achieve our ultimate goal of understanding cancer dormancy and progression, we need to develop robust models that incorporate appropriate cell-level tumor-host interactions that are informed by experiments. For example, by explicitly considering angiogenesis and using more realistic distribution of "transformed" tumor cells' resistance to microenvironmental suppression factors (currently we just divide the "transformed" cells into two types with respect to their resistance to microenvironmental suppression factors: weak and strong), our model might be able to yield more realistic results and improve our understanding of cancer dormancy and progression. Also, the effects of tumor cell competition, cooperation and the microenvironmental changes caused by tumor cell activities could be incorporated to further strengthen our CA dormancy model [60] . It is noteworthy that although we employ interaction rules based on a discrete cell model to describe "competition" between the tumor and the microenvironmental suppression factors, alternatives such as evolutionary game theory implemented by partial-differential equations are also available to address the interplay between the tumor and the microenvironment [61] .
